<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet type="text/css" href="uslm.css"?><pLaw xmlns="http://schemas.gpo.gov/xml/uslm" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" xsi:schemaLocation="http://schemas.gpo.gov/xml/uslm https://www.govinfo.gov/schemas/xml/uslm/uslm-2.0.17.xsd">

<?I97 ??>
<?I50 PUBLIC LAW 116–8—MAR. 8, 2019?>


<?I97 133 STAT. ?>
<?I98 133 STAT. ?>
<?I99 133 STAT. ?>
<?I50 PUBLIC LAW 116–8—MAR. 8, 2019?>
<?I51 PUBLIC LAW 116–8—MAR. 8, 2019?>
<?I52 PUBLIC LAW 116–8—MAR. 8, 2019?>


<!--Disclaimer: Legislative measures that include compacts or other non-standard data structures will require additional modeling and may contain inconsistencies in the converted USLM XML.-->
<meta><dc:title>Public Law 116–8: To enact into law a bill by reference.</dc:title>
<dc:type>Public Law</dc:type><docNumber>8</docNumber>
<citableAs>Public Law 116–8</citableAs><citableAs>133 Stat. 484</citableAs>
<approvedDate>2019-03-08</approvedDate>
<dc:date>2019-03-08</dc:date>
<dc:publisher>United States Government Publishing Office</dc:publisher><dc:creator>National Archives and Records Administration</dc:creator><dc:creator>Office of the Federal Register</dc:creator><dc:format>text/xml</dc:format><dc:language>EN</dc:language><dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
<processedBy>GPO Locator to USLM Converter 4.15.31;Stage2.20250702</processedBy><processedDate>2026-01-02</processedDate>
<congress>116</congress><publicPrivate>public</publicPrivate>
</meta>
<preface><page display="no">?483</page><note role="coverPage"><centerRunningHead>PUBLIC LAW 116–8—MAR. 8, 2019</centerRunningHead>
<coverTitle>PESTICIDE REGISTRATION IMPROVEMENT EXTENSION ACT OF 2018</coverTitle>
</note>
<page identifier="/us/stat/133/484">133 STAT. 484</page>
<dc:type>Public Law</dc:type><docNumber>116–8</docNumber>
<congress value="116">116th Congress</congress>
</preface>
<main>
<longTitle>
<docTitle class="centered fontsize12" style="-uslm-lc:I658005">An Act</docTitle>
<officialTitle class="indentUp0 firstIndent1 fontsize8" style="-uslm-lc:I658011">To enact into law a bill by reference.<sidenote><p class="centered fontsize8" id="xbce396e1-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658076"><approvedDate date="2019-03-08">Mar. 8, 2019</approvedDate></p><p class="centered fontsize8" id="xbce396e2-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658076">[<ref href="/us/bill/116/s/483">S. 483</ref>]<?GPOvSpace 08?></p></sidenote></officialTitle>
</longTitle>
<enactingFormula style="-uslm-lc:I658120"><i>  Be it enacted by the Senate and House of Representa­tives of the United States of America in Congress assembled,</i></enactingFormula><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce396e3-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Pesticide Registration Improvement Extension Act</p><p class="leftAlign firstIndent0 fontsize8" id="xbce396e4-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">of 2018.</p></sidenote>
<section id="d163679e100" identifier="/us/pl/116/8/s1" style="-uslm-lc:I658146"><num class="bold" value="1">SECTION 1. </num><heading>SHORT TITLE; TABLE OF CONTENTS.</heading><subsection class="firstIndent0 fontsize10" id="ybce3bdf5-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s1/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Short Title</inline><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce3bdf6-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180"><ref href="/us/usc/t7/s136">7 USC 136 note</ref>.</p></sidenote>.—</heading><content>This Act may be cited as the “<shortTitle role="act">Pesticide Registration Improvement Extension Act of 2018</shortTitle>”.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="ybce3bdf7-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s1/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Table of Contents</inline>.—</heading><content>The table of contents for this Act is as follows:<?GPOvSpace 04?>
<toc>
<referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 1. </designator>
<label>Short title; table of contents.</label>
</referenceItem><referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 2. </designator>
<label>Extension and modification of maintenance fee authority.</label>
</referenceItem><referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 3. </designator>
<label>Reregistration and Expedited Processing Fund.</label>
</referenceItem><referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 4. </designator>
<label>Experimental use permits for pesticides.</label>
</referenceItem><referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 5. </designator>
<label>Pesticide registration service fees.</label>
</referenceItem><referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 6. </designator>
<label>Revision of tables regarding covered pesticide registration applications and other covered actions and their corresponding registration service fees.</label>
</referenceItem><referenceItem role="section" style="-uslm-lc:I658242">
<designator>Sec. 7. </designator>
<label>Agricultural worker protection standard; certification of pesticide applicators.</label>
</referenceItem></toc>
</content></subsection>
</section>
<section id="d163679e173" identifier="/us/pl/116/8/s2" style="-uslm-lc:I658141"><num class="fontsize12" value="2">SEC. 2. </num><heading>EXTENSION AND MODIFICATION OF MAINTENANCE FEE AUTHORITY.</heading><subsection class="firstIndent0 fontsize10" id="ybce45a38-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Maintenance Fee</inline>.—</heading><chapeau>Section 4(i)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136a–1/i/1">7 U.S.C. 136a–1(i)(1)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce45a39-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in subparagraph (C), by <amendingAction type="delete">striking</amendingAction> “<quotedText>an aggregate amount of $27,800,000 for each of fiscal years 2013 through 2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>an average amount of $31,000,000 for each of fiscal years 2019 through 2023</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="ybce45a3a-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subparagraph (D)—</chapeau><subparagraph class="fontsize10" id="ybce45a3b-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in clause (i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$115,500 for each of fiscal years 2013 through 2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$129,400 for each of fiscal years 2019 through 2023</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce45a3c-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in clause (ii), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$184,800 for each of fiscal years 2013 through 2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$207,000 for each of fiscal years 2019 through 2023</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce45a3d-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><chapeau>in subparagraph (E)(i)—</chapeau><subparagraph class="fontsize10" id="ybce45a3e-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/3/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in subclause (I), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$70,600 for each of fiscal years 2013 through 2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$79,100 for each of fiscal years 2019 through 2023</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce45a3f-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/3/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subclause (II), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$122,100 for each of fiscal years 2013 through 2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$136,800 for each of fiscal years 2019 through 2023</quotedText>”; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce45a40-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/a/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>in subparagraph (I), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017..</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023.</quotedText>”.<page identifier="/us/stat/133/485">133 STAT. 485</page></content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce45a41-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Prohibition on Other Fees</inline>.—</heading><chapeau>Section 4(i)(2) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136a–1/i/2">7 U.S.C. 136a–1(i)(2)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce45a42-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>the date of enactment of this section and ending on September 30, 2019</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>the effective date of the Pesticide Registration Improvement Extension Act of 2018 and ending on September 30, 2025</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce45a43-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="insert">inserting</amendingAction> after “<quotedText>registration of a pesticide under this Act</quotedText>” the following: “<quotedText>or any other action covered under a table specified in section 33(b)(3),</quotedText>”.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce45a44-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s2/c" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><inline class="smallCaps">Extension of Prohibition on Tolerance Fees</inline>.—</heading><content>Section 408(m)(3) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/t21/s346a/m/3">21 U.S.C. 346a(m)(3)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”.</content></subsection>
</section>
<section id="d163679e337" identifier="/us/pl/116/8/s3" style="-uslm-lc:I658141"><num class="fontsize12" value="3">SEC. 3. </num><heading>REREGISTRATION AND EXPEDITED PROCESSING FUND.</heading><subsection class="firstIndent0 fontsize10" id="ybce51d95-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Authorized Use of Fund</inline>.—</heading><chapeau>Section 4(k)(2)(A) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136a–1/k/2/A">7 U.S.C. 136a–1(k)(2)(A)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce51d96-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in the first sentence, by <amendingAction type="delete">striking</amendingAction> “<quotedText>the fund</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>the Reregistration and Expedited Processing Fund</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="ybce51d97-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>paragraph (3),</quotedText>” in the first sentence and all that follows through the period at the end of the second sentence and <amendingAction type="insert">inserting</amendingAction> the following: “<quotedText>paragraph (3), to offset the costs of registration review under section 3(g), including the costs associated with any review under the Endangered Species Act of 1973 (<ref href="/us/usc/t16/s1531/etseq">16 U.S.C. 1531 et seq.</ref>) required as part of the registration review, to offset the costs associated with tracking and implementing registration review decisions, including registration review decisions designed to reduce risk, for the purposes specified in paragraphs (4) and (5), and to enhance the information systems capabilities to improve the tracking of pesticide registration decisions.</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="ybce51d98-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/a/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in clause (i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>are allocated solely</quotedText>” and all that follows through “<quotedText>3(g);</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following: “<quotedText>are allocated solely for the purposes specified in the first sentence of this subparagraph;</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce51d99-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/a/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>in clause (ii), by <amendingAction type="delete">striking</amendingAction> “<quotedText>necessary to achieve</quotedText>” and all that follows through “<quotedText>3(g);</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following: “<quotedText>necessary to achieve the purposes specified in the first sentence of this subparagraph;</quotedText>”.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce51d9a-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Set-Aside for Review of Inert Ingredients and Expedited Processing of Similar Applications</inline>.—</heading><content>Section 4(k)(3)(A) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136a–1/k/3/A">7 U.S.C. 136a–1(k)(3)(A)</ref>) <amendingAction type="amend">is amended</amendingAction>, in the matter preceding clause (i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>The Administrator shall use</quotedText>” and all that follows through “<quotedText>personnel and resources—</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following: “<quotedText>For each of fiscal years 2018 through 2023, the Administrator shall use between ⅑ and ⅛ of the maintenance fees collected in such fiscal year to obtain sufficient personnel and resources—</quotedText>”.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="ybce51d9b-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/c" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><inline class="smallCaps">Set-Aside for Expedited Rulemaking and Guidance Development for Certain Purposes</inline>.—</heading><content>Paragraph (4) of section 4(k) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136a–1/k">7 U.S.C. 136a–1(k)</ref>) <amendingAction type="amend">is amended</amendingAction> to read as follows:<quotedContent><paragraph class="fontsize10" id="ybce592cc-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">“(4) </num><heading class="fontsize10"><inline class="smallCaps">Expedited rulemaking and guidance development for certain product performance data requirements</inline>.—</heading><page identifier="/us/stat/133/486">133 STAT. 486</page>
<subparagraph class="fontsize10" id="ybce592cd-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><heading class="fontsize10"><inline class="smallCaps">Set-aside</inline>.—</heading><content>For each of fiscal years 2018 through 2023, the Administrator shall use not more than $500,000 of the amounts made available to the Administrator in the Reregistration and Expedited Processing Fund for the activities described in subparagraph (B).</content></subparagraph>
<subparagraph class="fontsize10" id="ybce592ce-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><heading class="fontsize10"><inline class="smallCaps">Products claiming efficacy against invertebrate pests of significant public health or economic importance</inline><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce592cf-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Evaluation.</p></sidenote>.—</heading><chapeau>The Administrator shall use amounts made available under subparagraph (A) to develop, receive comments with respect to, finalize, and implement the necessary rulemaking and guidance for product performance data requirements to evaluate products claiming efficacy against the following invertebrate pests of significant public health or economic importance (in order of importance):</chapeau><clause class="fontsize10" id="ybce592d0-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><content>Bed bugs.</content></clause>
<clause class="fontsize10" id="ybce592d1-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><content>Premise (including crawling insects, flying insects, and baits).</content></clause>
<clause class="fontsize10" id="ybce592d2-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iii">“(iii) </num><content>Pests of pets (including pet pests controlled by spot-ons, collars, shampoos, powders, or dips).</content></clause>
<clause class="fontsize10" id="ybce592d3-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iv">“(iv) </num><content>Fire ants.</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce592d4-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><heading class="fontsize10"><inline class="smallCaps">Deadlines for guidance</inline><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce592d5-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Publication.</p></sidenote>.—</heading><chapeau>The Administrator shall develop, and publish guidance required by subparagraph (B), with respect to claims of efficacy against pests described in such subparagraph as follows:</chapeau><clause class="fontsize10" id="ybce592d6-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><content>With respect to bed bugs, issue final guidance not later than 30 days after the effective date of the Pesticide Registration Improvement Extension Act of 2018.</content></clause>
<clause class="fontsize10" id="ybce592d7-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><chapeau>With respect to pests specified in clause (ii) of such subparagraph—</chapeau><subclause class="fontsize10" id="ybce592d8-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">“(I) </num><content>submit draft guidance to the Scientific Advisory Panel and for public comment not later than June 30, 2018; and</content></subclause>
<subclause class="fontsize10" id="ybce592d9-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">“(II) </num><content>complete any response to comments received with respect to such draft guidance and finalize the guidance not later than September 30, 2019.</content></subclause>
</clause>
<clause class="fontsize10" id="ybce592da-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iii">“(iii) </num><chapeau>With respect to pests specified in clauses (iii) and (iv) of such subparagraph—</chapeau><subclause class="fontsize10" id="ybce592db-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">“(I) </num><content>submit draft guidance to the Scientific Advisory Panel and for public comment not later than June 30, 2019; and</content></subclause>
<subclause class="fontsize10" id="ybce592dc-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">“(II) </num><content>complete any response to comments received with respect to such draft guidance and finalize the guidance not later than March 31, 2021.</content></subclause>
</clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce592dd-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">“(D) </num><heading class="fontsize10"><inline class="smallCaps">Revision</inline>.—</heading><content>The Administrator shall revise the guidance required by subparagraph (B) from time to time, but shall permit applicants and registrants sufficient time to obtain data that meet the requirements specified in such revised guidance.</content></subparagraph>
<subparagraph class="fontsize10" id="ybce592de-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="E">“(E) </num><heading class="fontsize10"><inline class="smallCaps">Deadline for product performance data requirements</inline>.—</heading><content>The Administrator shall, not later than September 30, 2021, issue regulations prescribing product performance data requirements for any pesticide intended for preventing, destroying, repelling, or mitigating any invertebrate pest of significant public health or economic <page identifier="/us/stat/133/487">133 STAT. 487</page>
importance specified in clauses (i) through (iv) of subparagraph (B).”</content></subparagraph>
</paragraph>
</quotedContent>.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="ybce592df-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/d" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="d">(d) </num><heading class="fontsize10"><inline class="smallCaps">Set-Aside for Good Laboratory Practices Inspections</inline>.—</heading><chapeau>Section 4(k) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136a–1/k">7 U.S.C. 136a–1(k)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce592e0-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/d/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> paragraphs (5) and (6) as paragraphs (6) and (7), respectively;</content></paragraph>
<paragraph class="fontsize10" id="ybce592e1-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/d/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="insert">inserting</amendingAction> after paragraph (4) the following new paragraph:<quotedContent><paragraph class="indentUp0 fontsize10" id="ybce5b9f2-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">“(5) </num><heading class="fontsize10"><inline class="smallCaps">Good laboratory practices inspections</inline>.—</heading><subparagraph class="fontsize10" id="ybce5b9f3-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><heading class="fontsize10"><inline class="smallCaps">Set-aside</inline>.—</heading><content>For each of fiscal years 2018 through 2023, the Administrator shall use not more than $500,000 of the amounts made available to the Administrator in the Reregistration and Expedited Processing Fund for the activities described in subparagraph (B).</content></subparagraph>
<subparagraph class="fontsize10" id="ybce5b9f4-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><heading class="fontsize10"><inline class="smallCaps">Activities</inline>.—</heading><content>The Administrator shall use amounts made available under subparagraph (A) for enhancements to the good laboratory practices standards compliance monitoring program established under <ref href="/us/cfr/t40/pt160">part 160 of title 40 of the Code of Federal Regulations</ref> (or successor regulations), with respect to laboratory inspections and data audits conducted in support of pesticide product registrations under this Act.<sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce5b9f5-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Deadline.</p></sidenote> As part of such monitoring program, the Administrator shall make available to each laboratory inspected under such program in support of such registrations a preliminary summary of inspection observations not later than 60 days after the date on which such an inspection is completed.”</content></subparagraph>
</paragraph>
</quotedContent>; and</content></paragraph>
<paragraph class="fontsize10" id="ybce5b9f6-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s3/d/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in paragraph (7), as so redesignated, by <amendingAction type="delete">striking</amendingAction> “<quotedText>paragraphs (2), (3), and (4)</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>paragraphs (2), (3), (4), and (5)</quotedText>”.</content></paragraph>
</subsection>
</section>
<section id="d163679e654" identifier="/us/pl/116/8/s4" role="instruction" style="-uslm-lc:I658141"><num class="fontsize12" value="4">SEC. 4. </num><heading>EXPERIMENTAL USE PERMITS FOR PESTICIDES.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="xbce5e107-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658120">  Section 5(a) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136c/a">7 U.S.C. 136c(a)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce5e108-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s4/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>permit for a pesticide.</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>permit for a pesticide. An application for an experimental use permit for a covered application under section 33(b) shall conform with the requirements of that section.</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce5e109-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s4/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>(or in the case of an application for an experimental use permit for a covered application under section 33(b), not later than the last day of the applicable timeframe for such application specified in such section)</quotedText>” after “<quotedText>all required supporting data</quotedText>”.</content></paragraph>
</section>
<section id="d163679e688" identifier="/us/pl/116/8/s5" style="-uslm-lc:I658141"><num class="fontsize12" value="5">SEC. 5. </num><heading>PESTICIDE REGISTRATION SERVICE FEES.</heading><subsection class="firstIndent0 fontsize10" id="ybce8520a-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Extension and Modification of Fee Authority</inline>.—</heading><chapeau>Section 33(b) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/b">7 U.S.C. 136w–8(b)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce8520b-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>in paragraph (2)—</chapeau><subparagraph class="fontsize10" id="ybce8520c-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in the heading, by <amendingAction type="delete">striking</amendingAction> “<quotedText><headingText class="smallCaps">pesticide registration</headingText></quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce8520d-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (A), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>or for any other action covered by a table specified in paragraph (3)</quotedText>” after “<quotedText>covered by this Act that is received by the Administrator on or after the effective date of the Pesticide Registration Improvement Act of 2003</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce8520e-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in paragraph (5)—<page identifier="/us/stat/133/488">133 STAT. 488</page></chapeau><subparagraph class="fontsize10" id="ybce8520f-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in the heading, by <amendingAction type="delete">striking</amendingAction> “<quotedText><headingText class="smallCaps">pesticide registration applications</headingText></quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText><headingText class="smallCaps">covered applications</headingText></quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce85210-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration application</quotedText>” both places it appears and <amendingAction type="insert">inserting</amendingAction> “<quotedText>covered application</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce87821-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><chapeau>in paragraph (6)—</chapeau><subparagraph class="fontsize10" id="ybce87822-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><chapeau>in subparagraph (A)—</chapeau><clause class="fontsize10" id="ybce87823-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/A/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>”; and</content></clause>
<clause class="fontsize10" id="ybce87824-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/A/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>October 1, 2013, and ending on September 30, 2015</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>October 1, 2019, and ending on September 30, 2021</quotedText>”;</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce87825-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><chapeau>in subparagraph (B)—</chapeau><clause class="fontsize10" id="ybce87826-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/B/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>”; and</content></clause>
<clause class="fontsize10" id="ybce87827-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/B/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>2015</quotedText>” each place it appears and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2021</quotedText>”; and</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce87828-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/3/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>in subparagraph (C), by <amendingAction type="delete">striking</amendingAction> “<quotedText>revised registration service fee schedules</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>service fee schedules revised pursuant to this paragraph</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce87829-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><chapeau>in paragraph (7)—</chapeau><subparagraph class="fontsize10" id="ybce8782a-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/4/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><chapeau>in subparagraph (A)—</chapeau><clause class="fontsize10" id="ybce8782b-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/4/A/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>covered pesticide registration</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>covered application</quotedText>”; and</content></clause>
<clause class="fontsize10" id="ybce8782c-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/4/A/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="insert">inserting</amendingAction> before the period at the end the following: “<quotedText>, except that no waiver or fee reduction shall be provided in connection with a request for a letter of certification (commonly referred to as a Gold Seal letter)</quotedText>”; and</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce8782d-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/4/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (F)(i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>”; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce8782e-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/5" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">(5) </num><chapeau>in paragraph (8)—</chapeau><subparagraph class="fontsize10" id="ybce8782f-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/5/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="ybce87830-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/5/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (B)(i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce87831-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/5/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><chapeau>in subparagraph (C)—</chapeau><clause class="fontsize10" id="ybce87832-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/5/C/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>in clause (i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>covered</quotedText>”; and</content></clause>
<clause class="fontsize10" id="ybce87833-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/a/5/C/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>in clause (ii)(I), by <amendingAction type="delete">striking</amendingAction> “<quotedText>pesticide registration</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>covered</quotedText>”.</content></clause>
</subparagraph>
</paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce87834-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Pesticide Registration Fund Set-Asides for Worker Protection, Partnership Grants, and Pesticide Safety Education</inline>.—</heading><chapeau>Section 33(c)(3)(B) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/c/3/B">7 U.S.C. 136w–8(c)(3)(B)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce87835-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in the heading, by <amendingAction type="insert">inserting</amendingAction> “<quotedText><headingText class="smallCaps">, partnership grants, and pesticide safety education</headingText></quotedText>” after “<quotedText><headingText class="smallCaps">Worker protection</headingText></quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="ybce87836-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in clause (i)—</chapeau><subparagraph class="fontsize10" id="ybce87837-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce87838-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="insert">inserting</amendingAction> before the period at the end the following:“<quotedText>, with an emphasis on field-worker populations in the United States</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce87839-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in clause (ii), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce8783a-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/b/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>in clause (iii), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce8783b-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/c" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><inline class="smallCaps">Reforms To Reduce Decision Time Review Periods</inline>.—</heading><chapeau>Section 33(e) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/e">7 U.S.C. 136w–8(e)</ref>) <amendingAction type="amend">is amended</amendingAction>—<page identifier="/us/stat/133/489">133 STAT. 489</page></chapeau><paragraph class="fontsize10" id="ybce8783c-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/c/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>Pesticide Registration Improvement Extension Act of 2012</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Pesticide Registration Improvement Extension Act of 2018</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce8783d-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/c/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="insert">inserting</amendingAction> at the end the following new sentence: “<quotedText>Such reforms shall include identifying opportunities for streamlining review processes for applications for a new active ingredient or a new use and providing prompt feedback to applicants during such review process.</quotedText>”.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce8783e-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="d">(d) </num><heading class="fontsize10"><inline class="smallCaps">Decision Time Review Periods</inline>.—</heading><chapeau>Section 33(f) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/f">7 U.S.C. 136w–8(f)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce8783f-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>in paragraph (1)—</chapeau><subparagraph class="fontsize10" id="ybce87840-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>Pesticide Registration Improvement Extension Act of 2012</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Pesticide Registration Improvement Extension Act of 2018</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce87841-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="insert">inserting</amendingAction> after “<quotedText>covered pesticide registration actions</quotedText>” the following: “<quotedText>or for any other action covered by a table specified in subsection (b)(3)</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybce87842-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>in paragraph (3), by <amendingAction type="delete">striking</amendingAction> subparagraph (C) and <amendingAction type="insert">inserting</amendingAction> the following new subparagraph:<quotedContent><subparagraph class="fontsize10" id="ybce87843-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><content>applications for any other action covered by a table specified in subsection (b)(3).”</content></subparagraph>
</quotedContent>; and</content></paragraph>
<paragraph class="fontsize10" id="ybce87844-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><chapeau>in paragraph (4)(A)—</chapeau><subparagraph class="fontsize10" id="ybce87845-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/3/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>a pesticide registration application</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>a covered application</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce87846-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/d/3/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>covered pesticide registration application</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>covered application</quotedText>”.</content></subparagraph>
</paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce87847-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="e">(e) </num><heading class="fontsize10"><inline class="smallCaps">Reporting Requirements</inline>.—</heading><chapeau>Section 33(k) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/k">7 U.S.C. 136w–8(k)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce87848-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in paragraph (1) by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce87849-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in paragraph (2)—</chapeau><subparagraph class="fontsize10" id="ybce8784a-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in subparagraph (D), by <amendingAction type="delete">striking</amendingAction> clause (i) and <amendingAction type="insert">inserting</amendingAction> the following new clause:<quotedContent><clause class="fontsize10" id="ybce89f5b-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><chapeau>the number of pesticides or pesticide cases reviewed and the number of registration review decisions completed, including—</chapeau><subclause class="fontsize10" id="ybce89f5c-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">“(I) </num><content>the number of cases cancelled;</content></subclause>
<subclause class="fontsize10" id="ybce89f5d-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">“(II) </num><content>the number of cases requiring risk mitigation measures;</content></subclause>
<subclause class="fontsize10" id="ybce89f5e-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="III">“(III) </num><content>the number of cases removing risk mitigation measures;</content></subclause>
<subclause class="fontsize10" id="ybce89f5f-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="IV">“(IV) </num><content>the number of cases with no risk mitigation needed; and</content></subclause>
<subclause class="fontsize10" id="ybce89f60-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="V">“(V) </num><content>the number of cases in which risk mitigation has been fully implemented;”</content></subclause>
</clause>
</quotedContent>;</content></subparagraph>
<subparagraph class="fontsize10" id="ybce89f61-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><chapeau>in subparagraph (G)—</chapeau><clause class="fontsize10" id="ybce89f62-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><chapeau>in clause (i)—</chapeau><subclause class="fontsize10" id="ybce89f63-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B/i/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>section 4(k)(4)</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>paragraphs (4) and (5) of section 4(k)</quotedText>”; and</content></subclause>
<subclause class="fontsize10" id="ybce89f64-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B/i/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>that section</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>such paragraphs</quotedText>”;</content></subclause>
</clause>
<clause class="fontsize10" id="ybce89f65-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="delete">striking</amendingAction> clauses (ii), (iii), (iv), (v), and (vi);</content></clause>
<clause class="fontsize10" id="ybce89f66-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B/iii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iii">(iii) </num><content>by <amendingAction type="insert">inserting</amendingAction> after clause (i) the following new clause:<quotedContent><clause class="indentUp0 fontsize10" id="ybce8c677-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><chapeau>implementing enhancements to—<page identifier="/us/stat/133/490">133 STAT. 490</page></chapeau><subclause class="fontsize10" id="ybce8c678-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">“(I) </num><content>the electronic tracking of covered applications;</content></subclause>
<subclause class="fontsize10" id="ybce8c679-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">“(II) </num><content>the electronic tracking of conditional registrations;</content></subclause>
<subclause class="fontsize10" id="ybce8c67a-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="III">“(III) </num><content>the endangered species database;</content></subclause>
<subclause class="fontsize10" id="ybce8c67b-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="IV">“(IV) </num><content>the electronic review of labels submitted with covered applications; and</content></subclause>
<subclause class="fontsize10" id="ybce8c67c-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="V">“(V) </num><content>the electronic review and assessment of confidential statements of formula submitted with covered applications; and”</content></subclause>
</clause>
</quotedContent>; and</content></clause>
<clause class="fontsize10" id="ybce8c67d-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/B/iv" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iv">(iv) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> clause (vii) as clause (iii);</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce8c67e-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>in subparagraph (I), by <amendingAction type="delete">striking</amendingAction> “<quotedText>and</quotedText>” at the end;</content></subparagraph>
<subparagraph class="fontsize10" id="ybce8c67f-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>in subparagraph (J), by <amendingAction type="delete">striking</amendingAction> the period at the end and <amendingAction type="insert">inserting</amendingAction> a semicolon; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce8c680-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/e/2/E" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="E">(E) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce8c681-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Reviews.</p></sidenote><content>by <amendingAction type="add">adding</amendingAction> at the end the following new subparagraphs:<quotedContent><subparagraph class="indentUp0 fontsize10" id="ybce914a2-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="K">“(K) </num><content>a review of the progress made in developing, updating, and implementing product performance test guidelines for pesticide products that are intended to control invertebrate pests of significant public health importance and, by regulation, prescribing product performance data requirements for such pesticide products registered under section 3;</content></subparagraph>
<subparagraph class="indentUp0 fontsize10" id="ybce914a3-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="L">“(L) </num><content>a review of the progress made in the priority review and approval of new pesticides to control invertebrate public health pests that may transmit vector-borne disease for use in the United States, including each territory or possession of the United States, and United States military installations globally;</content></subparagraph>
<subparagraph class="indentUp0 fontsize10" id="ybce914a4-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="M">“(M) </num><content>a review of the progress made in implementing enhancements to the good laboratory practices standards compliance monitoring program established under <ref href="/us/cfr/t40/pt160">part 160 of title 40 of the Code of Federal Regulations</ref> (or successor regulations);</content></subparagraph>
<subparagraph class="indentUp0 fontsize10" id="ybce914a5-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="N">“(N) </num><content>the number of approvals for active ingredients, new uses, and pesticide end use products granted in connection with the Design for the Environment program (or any successor program) of the Environmental Protection Agency; and</content></subparagraph>
<subparagraph class="indentUp0 fontsize10" id="ybce914a6-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="O">“(O) </num><chapeau>with respect to funds in the Pesticide Registration Fund reserved under subsection (c)(3), a review that includes—</chapeau><clause class="fontsize10" id="ybce914a7-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><chapeau>a description of the amount and use of such funds—</chapeau><subclause class="fontsize10" id="ybce914a8-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">“(I) </num><content>to carry out activities relating to worker protection under clause (i) of subsection (c)(3)(B);</content></subclause>
<subclause class="fontsize10" id="ybce914a9-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">“(II) </num><content>to award partnership grants under clause (ii) of such subsection; and</content></subclause>
<subclause class="fontsize10" id="ybce914aa-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="III">“(III) </num><content>to carry out the pesticide safety education program under clause (iii) of such subsection;</content></subclause>
</clause>
<clause class="fontsize10" id="ybce914ab-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce914ac-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Evaluation.</p></sidenote><content>an evaluation of the appropriateness and effectiveness of the activities, grants, and program described in clause (i);</content></clause>
<clause class="fontsize10" id="ybce914ad-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iii">“(iii) </num><content>a description of how stakeholders are engaged in the decision to fund such activities, grants, and program; and<page identifier="/us/stat/133/491">133 STAT. 491</page></content></clause>
<clause class="fontsize10" id="ybce914ae-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iv">“(iv) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce914af-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Summary.</p></sidenote><content>with respect to activities relating to worker protection carried out under subparagraph (B)(i) of such subsection, a summary of the analyses from stakeholders, including from worker community-based organizations, on the appropriateness and effectiveness of such activities.”</content></clause>
</subparagraph>
</quotedContent>.</content></subparagraph>
</paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybce914b0-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="f">(f) </num><heading class="fontsize10"><inline class="smallCaps">Termination of Effectiveness</inline>.—</heading><chapeau>Section 33(m) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/m">7 U.S.C. 136w–8(m)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="ybce914b1-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in paragraph (1), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="ybce914b2-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in paragraph (2)—</chapeau><subparagraph class="fontsize10" id="ybce914b3-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><chapeau>in subparagraph (A)—</chapeau><clause class="fontsize10" id="ybce914b4-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/A/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText><headingText class="smallCaps">Fiscal year 2018</headingText>.—During fiscal year 2018</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText><headingText class="smallCaps">Fiscal year 2024</headingText>.—During fiscal year 2024</quotedText>”; and</content></clause>
<clause class="fontsize10" id="ybce914b5-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/A/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”;</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce914b6-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><chapeau>in subparagraph (B)—</chapeau><clause class="fontsize10" id="ybce914b7-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/B/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText><headingText class="smallCaps">Fiscal year 2019</headingText>.—During fiscal year 2019</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText><headingText class="smallCaps">Fiscal year 2025</headingText>.—During fiscal year 2025</quotedText>”; and</content></clause>
<clause class="fontsize10" id="ybce914b8-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/B/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”;</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="ybce914b9-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>in subparagraph (C), by <amendingAction type="delete">striking</amendingAction> “<quotedText><headingText class="smallCaps">September 30, 2019</headingText>.—Effective September 30, 2019</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText><headingText class="smallCaps">September 30, 2025</headingText>.—Effective September 30, 2025</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="ybce914ba-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s5/f/2/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>in subparagraph (D), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2017</quotedText>” both places it appears and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2023</quotedText>”.</content></subparagraph>
</paragraph>
</subsection>
</section>
<section id="d163679e1560" identifier="/us/pl/116/8/s6" role="instruction" style="-uslm-lc:I658141"><num class="fontsize12" value="6">SEC. 6. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbce914bb-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Extension.</p><p class="leftAlign firstIndent0 fontsize8" id="xbce914bc-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Notification.</p><p class="leftAlign firstIndent0 fontsize8" id="xbce914bd-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Time period.</p><p class="leftAlign firstIndent0 fontsize8" id="xbce914be-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Deadline.</p></sidenote><heading>REVISION OF TABLES REGARDING COVERED PESTICIDE REGISTRATION APPLICATIONS AND OTHER COVERED ACTIONS AND THEIR CORRESPONDING REGISTRATION SERVICE FEES.</heading><content class="firstIndent0 fontsize10" id="xbcee1dcf-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658120">  Paragraph (3) of section 33(b) of the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136w–8/b">7 U.S.C. 136w–8(b)</ref>) <amendingAction type="amend">is amended</amendingAction> to read as follows:<quotedContent><paragraph class="fontsize10" id="ybcee1dd0-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><heading class="fontsize10"><inline class="smallCaps">Schedule of covered applications and other actions and their registration service fees</inline>.—</heading><content>Subject to paragraph (6), the schedule of registration applications and other covered actions and their corresponding registration service fees shall be as follows:<?GPOvSpace 00?></content></paragraph>
</quotedContent><xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 1. — REGISTRATION DIVISION — NEW ACTIVE INGREDIENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e1150"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1150"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e1158"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/495">133 STAT. 495</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1167"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R010</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Food use. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 753,082</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R020</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Food use; reduced risk. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">627,568</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/492">133 STAT. 492</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R040</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Food use; Experimental Use Permit application; establish temporary tolerance; submitted before application for registration; credit 45% of fee toward new active ingredient application that follows. <ref class="footnoteRef" idref="fn-d163463e1167">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">462,502</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R060</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; outdoor. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 523,205</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R070</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; outdoor; reduced risk. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">16</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">436,004</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R090</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; outdoor; Experimental Use Permit application; submitted before application for registration; credit 45% of fee toward new active ingredient application that follows. <ref class="footnoteRef" idref="fn-d163463e1167">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">16</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">323,690</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/493">133 STAT. 493</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R110</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; indoor. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">20</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">290,994</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R120</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; indoor; reduced risk. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">14</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">242,495</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R121</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; indoor; Experimental Use Permit application; submitted before application for registration; credit 45% of fee toward new active ingredient application that follows. <ref class="footnoteRef" idref="fn-d163463e1167">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">182,327</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R122</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Enriched isomer(s) of registered mixed-isomer active ingredient. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">317,128</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R123</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Seed treatment only; includes agricultural and non-agricultural seeds; residues not expected in raw agricultural commodities. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">471,861</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/494">133 STAT. 494</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">R125</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Seed treatment; Experimental Use Permit application; submitted before application for registration; credit 45% of fee toward new active ingredient application that follows. <ref class="footnoteRef" idref="fn-d163463e1167">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">16</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">323,690</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9j,8C,xl72,xl49C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 2. — REGISTRATION DIVISION — NEW USES</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 156pt;"/>
<xhtml:col role="reading" style="min-width: 126pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b>CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 156.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 126.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b> Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e1385"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e1385"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/499">133 STAT. 499</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1394"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e1402"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/500">133 STAT. 500</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1411"><num>(4)</num> Amendment applications to add the new use(s) to registered product labels are covered by the base fee for the new use(s). All items in the covered application must be submitted together in one package. Each application for an additional new product registration and new inert approval(s) that is submitted in the new use application package is subject to the registration service fee for a new product or a new inert approval. However, if a new use application only proposes to register the new use for a new product and there are no amendments in the application, then review of one new product application is covered by the new use fee. All such associated applications that are submitted together will be subject to the new use decision review time. Any application for a new product or an amendment to the proposed labeling (a) submitted subsequent to submission of the new use application and (b) prior to conclusion of its decision review time and (c) containing the same new uses, will be deemed a separate new-use application, subject to a separate registration service fee and new decision review time for a new use. If the new-use application includes non-food (indoor and/or outdoor), and food (outdoor and/or indoor) uses, the appropriate fee is due for each type of new use and the longest decision review time applies to all of the new uses requested in the application. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screen, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new use application.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R130</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">First food use; indoor; food/food handling. <ref class="footnoteRef" idref="fn-d163463e1394">(2)</ref> <ref class="footnoteRef" idref="fn-d163463e1402">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">191,444</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R140</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">14</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food use; Indoor; food/food handling. <ref class="footnoteRef" idref="fn-d163463e1402">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1411">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">44,672</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R150</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">First food use. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 317,104</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R155</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">16 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">First food use, Experimental Use Permit application; a.i. registered for non-food outdoor use. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">264,253</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R160</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">17</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">First food use; reduced risk. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">16</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">264,253</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R170</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food use. <ref class="footnoteRef" idref="fn-d163463e1402">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1411">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">79,349</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/496">133 STAT. 496</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R175</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food uses covered within a crop group resulting from the conversion of existing approved crop group(s) to one or more revised crop groups. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">66,124</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R180</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">20</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food use; reduced risk. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">66,124</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R190</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food uses; 6 or more submitted in one application. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">476,090</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R200</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">22</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional Food Use; 6 or more submitted in one application; Reduced Risk. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">396,742</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R210</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">23</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food use; Experimental Use Permit application; establish temporary tolerance; no credit toward new use registration. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">48,986</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/497">133 STAT. 497</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R220</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional food use; Experimental Use Permit application; crop destruct basis; no credit toward new use registration. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19,838</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R230</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">25</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional use; non-food; outdoor. <ref class="footnoteRef" idref="fn-d163463e1402">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1411">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,713</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R240</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">26</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional use; non-food; outdoor; reduced risk. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">26,427</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R250</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">27</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional use; non-food; outdoor; Experimental Use Permit application; no credit toward new use registration. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19,838</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R251</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">28</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Experimental Use Permit application which requires no changes to the tolerance(s); non-crop destruct basis. <ref class="footnoteRef" idref="fn-d163463e1402">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19,838</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R260</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">29</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use; non-food; indoor. <ref class="footnoteRef" idref="fn-d163463e1402">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1411">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15,317</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R270</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">30</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use; non-food; indoor; reduced risk. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/498">133 STAT. 498</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R271</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use; non-food; indoor; Experimental Use Permit application; no credit toward new use registration. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9,725</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R273</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">32</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional use; seed treatment; limited uptake into Raw Agricultural Commodities; includes crops with established tolerances (e.g., for soil or foliar application); includes food and/or non-food uses. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">50,445</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:right; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">R274</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">33</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Additional uses; seed treatment only; 6 or more submitted in one application; limited uptake into raw agricultural commodities; includes crops with established tolerances (e.g., for soil or foliar application); includes food and/or non-food uses. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">302,663</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl72,xl49C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 3. — REGISTRATION DIVISION — IMPORT AND OTHER TOLERANCES</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 156pt;"/>
<xhtml:col role="reading" style="min-width: 126pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b>CR</b><br/><b> No.</b></xhtml:th><xhtml:th style="min-width: 156.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 126.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b> Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e1757"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b> ($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1757"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e1765"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/504">133 STAT. 504</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1774"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e1782"><num>(4)</num> Amendment applications to add the revised use pattern(s) to registered product labels are covered by the base fee for the category. All items in the covered application must be submitted together in one package. Each application for an additional new product registration and new inert approval(s) that is submitted in the amendment application package is subject to the registration service fee for a new product or a new inert approval. However, if an amendment application only proposes to register the amendment for a new product and there are no amendments in the application, then review of one new product application is covered by the base fee. All such associated applications that are submitted together will be subject to the category decision review time.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R280</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">34</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish import tolerance; new active ingredient or first food use. <ref class="footnoteRef" idref="fn-d163463e1765">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">319,072</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R290</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">35</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish Import tolerance; Additional new food use.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63,816</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R291</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">36</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish import tolerances; additional food uses; 6 or more crops submitted in one petition.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">382,886</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/501">133 STAT. 501</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R292</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">37</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend an established tolerance (e.g., decrease or increase) and/or harmonize established tolerances with Codex MRLs; domestic or import; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">45,341</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R293</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">38</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish tolerance(s) for inadvertent residues in one crop; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">53,483</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R294</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">39</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish tolerances for inadvertent residues; 6 or more crops submitted in one application; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">320,894</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R295</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">40</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish tolerance(s) for residues in one rotational crop in response to a specific rotational crop application; submission of corresponding label amendments which specify the necessary plant-back restrictions; applicant-initiated. <ref class="footnoteRef" idref="fn-d163463e1774">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1782">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">66,124</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/502">133 STAT. 502</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R296</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">41</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Establish tolerances for residues in rotational crops in response to a specific rotational crop petition; 6 or more crops submitted in one application; submission of corresponding label amendments which specify the necessary plant-back restrictions; applicant-initiated. <ref class="footnoteRef" idref="fn-d163463e1774">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1782">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">396,742</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R297</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">42</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend 6 or more established tolerances (e.g., decrease or increase) in one petition; domestic or import; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">272,037</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R298</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">43</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend an established tolerance (e.g., decrease or increase); domestic or import; submission of corresponding amended labels (requiring science review). <ref class="footnoteRef" idref="fn-d163463e1774">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1782">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">58,565</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/503">133 STAT. 503</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">R299</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">44</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Amend 6 or more established tolerances (e.g., decrease or increase); domestic or import; submission of corresponding amended labels (requiring science review). <ref class="footnoteRef" idref="fn-d163463e1774">(3)</ref> <ref class="footnoteRef" idref="fn-d163463e1782">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">285,261</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/505">133 STAT. 505</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,7L,7C,xl75,xl50C,xl67C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 4. — REGISTRATION DIVISION — NEW PRODUCTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:35pt ; max-width:35pt;"/>
<xhtml:col role="figure" style="width:35pt ; max-width:35pt;"/>
<xhtml:col role="reading" style="min-width: 132pt;"/>
<xhtml:col role="reading" style="min-width: 102pt;"/>
<xhtml:col role="reading" style="min-width: 119pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:35.0pt ; max-width:35.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b> No</b>.</xhtml:th><xhtml:th style="width:35.0pt ; max-width:35.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 132.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 102.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e2004"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="min-width: 119.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2004"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e2012"><num>(2)</num> An application for a new end-use product using a source of active ingredient that (a) is not yet registered but (b) has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/517">133 STAT. 517</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2021"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2029"><num>(4)</num> For the purposes of classifying proposed registration actions into PRIA categories, “pest(s) requiring efficacy” are: public health pests listed in PR Notice 2002–1, livestock pests (e.g. Horn flies, Stable flies), wood-destroying pests (e.g. termites, carpenter ants, wood-boring beetles) and certain invasive species (e.g. Asian Longhorned beetle, Emerald Ashborer). This list may be updated/refined as invasive pest needs arise. To determine the number of pests for the PRIA categories, pests have been placed into groups (general; e.g., cockroaches) and pest specific (specifically a test species). If seeking a label claim against a pest group (general), use the group listing below and each group will count as 1. The general pests groups are: mites, dust mites, chiggers, ticks, hard ticks, soft ticks, cattle ticks, scorpions, spiders, centipedes, lice, fleas, cockroaches, keds, bot flies, screwworms, filth flies, blow flies, house flies, flesh flies, mosquitoes, biting flies, horse flies, stable flies, deer flies, sand flies, biting midges, black flies, true bugs, bed bugs, stinging bees, wasps, yellow jackets, hornets, ants (excluding carpenter ants), fire and harvester ants, wood destroying beetles, carpenter ants, termites, subterranean termites, dry wood termites, arboreal termites, damp wood termites and invasive species. If seeking a claim against a specific pest without a general claim then each specific pest will count as 1.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R300</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">45</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; or similar combination product (already registered) to an identical or substantially similar in composition and use to a registered product; registered source of active ingredient; no data review on acute toxicity, efficacy or CRP – only product chemistry data; cite-all data citation, or selective data citation where applicant owns all required data, or applicant submits specific authorization letter from data owner. Category also includes 100% re-package of registered end-use or manufacturing-use product that requires no data submission nor data matrix. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,582</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/506">133 STAT. 506</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R301</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">46</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; or similar combination product (already registered) to an identical or substantially similar in composition and use to a registered product; registered source of active ingredient; selective data citation only for data on product chemistry and/or acute toxicity and/or public health pest efficacy (identical data citation and claims to cited product(s)), where applicant does not own all required data and does not have a specific authorization letter from data owner. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,897</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/507">133 STAT. 507</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R310</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">47</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end-use or manufacturing-use product with registered source(s) of active ingredient(s); includes products containing two or more registered active ingredients previously combined in other registered products; excludes products requiring or citing an animal safety study; requires review of data package within RD only; includes data and/or waivers of data for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or• child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for up to 3 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>7,301</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/508">133 STAT. 508</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R314</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">48</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end use product containing up to three registered active ingredients never before registered as this combination in a formulated product; new product label is identical or substantially similar to the labels of currently registered products which separately contain the respective component active ingredients; excludes products requiring or citing an animal safety study; requires review of data package within RD only; includes data and/or waivers of data for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or • child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for up to 3 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>8,626</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/509">133 STAT. 509</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R319</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">49</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end use product containing up to three registered active ingredients never before registered as this combination in a formulated product; new product label is identical or substantially similar to the labels of currently registered products which separately contain the respective component active ingredients; excludes products requiring or citing an animal safety study; requires review of data package within RD only; includes data and/or waivers of data for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or • child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for 4 to 7 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>12,626</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/510">133 STAT. 510</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R318</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">50 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end use product containing four or more registered active ingredients never before registered as this combination in a formulated product; new product label is identical or substantially similar to the labels of currently registered products which separately contain the respective component active ingredients; excludes products requiring or citing an animal safety study; requires review of data package within RD only; includes data and/or waivers of data for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or• child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for up to 3 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>13,252</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/511">133 STAT. 511</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R321</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">51 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end use product containing four or more registered active ingredients never before registered as this combination in a formulated product; new product label is identical or substantially similar to the labels of currently registered products which separately contain the respective component active ingredients; excludes products requiring or citing an animal safety study; requires review of data package within RD only; includes data and/or waivers of data for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or• child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for 4 to 7 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>17,252</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/512">133 STAT. 512</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R315</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">52</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end-use, on-animal product, registered source of active ingredient(s), with the submission of data and/or waivers for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• animal safety and• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> and/or• product chemistry and/or• acute toxicity and/or • child resistant packaging. <ref class="footnoteRef" idref="fn-d163463e2012">(2)</ref> <ref class="footnoteRef" idref="fn-d163463e2021">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>9,820</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/513">133 STAT. 513</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R316</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">53 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end-use or manufacturing product with registered source(s) of active ingredient(s) including products containing two or more registered active ingredients previously combined in other registered products; excludes products requiring or citing an animal safety study; and requires review of data and/or waivers for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or • child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for greater than 3 and up to 7 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>11,301</inline></xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/514">133 STAT. 514</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R317</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">54 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New end-use or manufacturing product with registered source(s) of active ingredient(s) including products containing 2 or more registered active ingredients previously combined in other registered products; excludes products requiring or citing an animal safety study; and requires review of data and/or waivers for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or • child resistant packaging and/or• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2029">(4)</ref> - for greater than 7 target pests. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>15,301</inline></xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R320</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">55</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; new physical form; requires data review in science divisions. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13,226</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/515">133 STAT. 515</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R331</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">56</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; repack of identical registered end-use product as a manufacturing-use product, or identical registered manufacturing-use product as an end use product; same registered uses only. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,530</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R332</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">57</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New manufacturing-use product; registered active ingredient; unregistered source of active ingredient; submission of completely new generic data package; registered uses only; requires review in RD and science divisions. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">283,215</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/516">133 STAT. 516</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R333</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">58</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; MUP or End use product with unregistered source of active ingredient; requires science data review; new physical form; etc. Cite-all or selective data citation where applicant owns all required data. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19,838</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">R334</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">59</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New product; MUP or End use product with unregistered source of the active ingredient; requires science data review; new physical form; etc. Selective data citation. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">23,100</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/518">133 STAT. 518</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,7L,6C,xl86,xl43C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 5. — REGISTRATION DIVISION — AMENDMENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:35pt ; max-width:35pt;"/>
<xhtml:col role="figure" style="width:31pt ; max-width:31pt;"/>
<xhtml:col role="reading" style="min-width: 179pt;"/>
<xhtml:col role="reading" style="min-width: 121pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:35.0pt ; max-width:35.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b> No</b>.</xhtml:th><xhtml:th style="width:31.0pt ; max-width:31.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b>CR</b><br/><b> No.</b></xhtml:th><xhtml:th style="min-width: 179.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 121.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision Review</b><br/><b> Time</b><br/><b>(Months)</b><ref class="footnoteRef" idref="fn-d163463e2339"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b> ($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2339"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e2347"><num>(2)</num> (a) EPA-initiated amendments shall not be charged registration service fees. (b) Registrant-initiated fast-track amendments are to be completed within the timelines specified in FIFRA Section 3(c)(3)(B) and are not subject to registration service fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials Division are to be completed within the timelines specified in FIFRA Section 3(h) and are not subject to registration service fees. (d) Registrant initiated amendments submitted by notification under PR Notices, such as PR Notice 98–10, continue under PR Notice timelines and are not subject to registration service fees. (e) Submissions with data and requiring data review are subject to registration service fees.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/520">133 STAT. 520</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2356"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2364"><num>(4)</num> For the purposes of classifying proposed registration actions into PRIA categories, “pest(s) requiring efficacy” are: public health pests listed in PR Notice 2002–1, livestock pests (e.g. Horn flies, Stable flies), wood-destroying pests (e.g. termites, carpenter ants, wood-boring beetles) and certain invasive species (e.g. Asian Longhorned beetle, Emerald Ashborer). This list may be updated/refined as invasive pest needs arise. To determine the number of pests for the PRIA categories, pests have been placed into groups (general; e.g., cockroaches) and pest specific (specifically a test species). If seeking a label claim against a pest group (general), use the group listing below and each group will count as 1. The general pests groups are: mites, dust mites, chiggers, ticks, hard ticks, soft ticks, cattle ticks, scorpions, spiders, centipedes, lice, fleas, cockroaches, keds, bot flies, screwworms, filth flies, blow flies, house flies, flesh flies, mosquitoes, biting flies, horse flies, stable flies, deer flies, sand flies, biting midges, black flies, true bugs, bed bugs, stinging bees, wasps, yellow jackets, hornets, ants (excluding carpenter ants), fire and harvester ants, wood destroying beetles, carpenter ants, termites, subterranean termites, dry wood termites, arboreal termites, damp wood termites and invasive species. If seeking a claim against a specific pest without a general claim then each specific pest will count as 1.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R340</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">60</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment requiring data review within RD (e.g., changes to precautionary label statements); includes adding/modifying pest(s) claims for up to 2 target pests, excludes products requiring or citing an animal safety study. (2)(3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4,988</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R341</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">61 (New)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment requiring data review within RD (e.g., changes to precautionary label statements), includes adding/modifying pest(s) claims for greater than 2 target pests, excludes products requiring or citing an animal safety study. (2)(3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,988</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R345</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">62</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amending on-animal products previously registered, with the submission of data and/or waivers for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">• animal safety and• pest(s) requiring efficacy <ref class="footnoteRef" idref="fn-d163463e2364">(4)</ref> and/or• product chemistry and/or• acute toxicity and/or • child resistant packaging. (2)(3)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;">8,820</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/519">133 STAT. 519</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R350</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment requiring data review in science divisions (e.g., changes to REI, or PPE, or PHI, or use rate, or number of applications; or add aerial application; or modify GW/SW advisory statement). (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13,226</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R351</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">64</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment adding a new unregistered source of active ingredient. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13,226</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R352</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">65</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment adding already approved uses; selective method of support; does not apply if the applicant owns all cited data. <ref class="footnoteRef" idref="fn-d163463e2347">(2)</ref> <ref class="footnoteRef" idref="fn-d163463e2356">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13,226</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">R371</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">66</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Amendment to Experimental Use Permit; (does not include extending a permit’s time period). <ref class="footnoteRef" idref="fn-d163463e2356">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">10,090</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,8L,8C,xl73,xl50C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 6. — REGISTRATION DIVISION — OTHER ACTIONS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 160pt;"/>
<xhtml:col role="reading" style="min-width: 126pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b> No.</b></xhtml:th><xhtml:th style="min-width: 160.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 126.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision Review</b><br/><b> Time</b><br/><b>(Months)</b><ref class="footnoteRef" idref="fn-d163463e2521"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b> ($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2521"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R124</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">67</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Conditional Ruling on Pre-application Study Waivers; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,530</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/521">133 STAT. 521</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R272</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">68</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Review of Study Protocol applicant-initiated; excludes DART, pre-registration conference, Rapid Response review, DNT protocol review, protocol needing HSRB review.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,530</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">R275</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">69</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Rebuttal of agency reviewed protocol, applicant initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,530</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">R370</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">70</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Cancer reassessment; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">198,250</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,7C,xl76,xl39C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 7. — ANTIMICROBIALS DIVISION — NEW ACTIVE INGREDIENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:35pt ; max-width:35pt;"/>
<xhtml:col role="reading" style="min-width: 163pt;"/>
<xhtml:col role="reading" style="min-width: 124pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b> No</b>.</xhtml:th><xhtml:th style="width:35.0pt ; max-width:35.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b>CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 163.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 124.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b> Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e2629"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b> ($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2629"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e2637"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/523">133 STAT. 523</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2646"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A380</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">71</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient; Indirect Food use; establish tolerance or tolerance exemption if required. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">137,841</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/522">133 STAT. 522</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A390</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">72</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient; Direct Food use; establish tolerance or tolerance exemption if required. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">229,733</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A410</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">73</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient Non-food use.(2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">229,733</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">A431</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">74</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New Active Ingredient, Non-food use; low-risk. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">80,225</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,xl9,9C,xl65,xl50C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 8. — ANTIMICROBIALS DIVISION — NEW USES</xhtml:caption>
<xhtml:colgroup><xhtml:col role="reading" style="min-width: 53pt;"/>
<xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="reading" style="min-width: 142pt;"/>
<xhtml:col role="reading" style="min-width: 126pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="min-width: 53.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b> No</b>.</xhtml:th><xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 142.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 126.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e2755"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b> ($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2755"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e2763"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/525">133 STAT. 525</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2772"><num>(3)</num> If EPA data rules are amended to newly require clearance under section 408 of the FFDCA for an ingredient of an antimicrobial product where such ingredient was not previously subject to such a clearance, then review of the data for such clearance of such product is not subject to a registration service fee for the tolerance action for two years from the effective date of the rule.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2780"><num>(4)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2788"><num>(5)</num> Amendment applications to add the new use(s) to registered product labels are covered by the base fee for the new use(s). All items in the covered application must be submitted together in one package. Each application for an additional new product registration and new inert approval(s) that is submitted in the new use application package is subject to the registration service fee for a new product or a new inert approval. However, if a new use application only proposes to register the new use for a new product and there are no amendments in the application, then review of one new product application is covered by the new use fee. All such associated applications that are submitted together will be subject to the new use decision review time. Any application for a new product or an amendment to the proposed labeling (a) submitted subsequent to submission of the new use application and (b) prior to conclusion of its decision review time and (c) containing the same new uses, will be deemed a separate new-use application, subject to a separate registration service fee and new decision review time for a new use. If the new-use application includes non-food (indoor and/or outdoor), and food (outdoor and/or indoor) uses, the appropriate fee is due for each type of new use and the longest decision review time applies to all of the new uses requested in the application. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screen, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new use application.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A440</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">75</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Use, Indirect Food Use, establish tolerance or tolerance exemption. (2)(3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A441</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">76</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional Indirect food uses; establish tolerances or tolerance exemptions if required; 6 or more submitted in one application. (3)(4)(5)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">114,870</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A450</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">77</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use, Direct food use, establish tolerance or tolerance exemption. (2)(3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">95,724</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/524">133 STAT. 524</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A451</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">78</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Additional Direct food uses; establish tolerances or tolerance exemptions if required; 6 or more submitted in one application. (3)(4)(5)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">182,335</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A500</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">79</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use, non-food. (4)(5)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">A501</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">80</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New use, non-food; 6 or more submitted in one application. (4)(5)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">76,583</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/526">133 STAT. 526</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 9. — ANTIMICROBIALS DIVISION — NEW PRODUCTS AND AMENDMENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e2922"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2922"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2930"><num>(2)</num> An application for a new end-use product using a source of active ingredient that (a) is not yet registered but (b) has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e2938"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/531">133 STAT. 531</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2947"><num>(4)</num>(a) EPA-initiated amendments shall not be charged registration service fees. (b) Registrant-initiated fast-track amendments are to be completed within the timelines specified in FIFRA Section 3(c)(3)(B) and are not subject to registration service fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials Division are to be completed within the timelines specified in FIFRA Section 3(h) and are not subject to registration service fees. (d) Registrant initiated amendments submitted by notification under PR Notices, such as PR Notice 98–10, continue under PR Notice timelines and are not subject to registration service fees. (e) Submissions with data and requiring data review are subject to registration service fees.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2955"><num>(5)</num> The applicant must identify the substantially similar product if opting to use cite-all or the selective method to support acute toxicity data requirements.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2963"><num>(6)</num> Once a submission for a new product with public health organisms has been submitted and classified in either A540 or A541, additional organisms submitted for the same product before expiration of the first submission’s original decision review time period will result in reclassification of both the original and subsequent submission into the appropriate new category based on the sum of the number of organisms in both submissions. A reclassification would result in a new PRIA start date and require additional fees to meet the fee of the new category.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e2972"><num>(7)</num> Once a submission for a label amendment with public health organisms has been submitted and classified in either A570 or A573, additional organisms submitted for the same product before expiration of the first submission’s original decision review time period will result in reclassification of both the original and subsequent submission into the appropriate new category based on the sum of the number of organisms in both submissions. A reclassification would result in a new PRIA start date and require additional fees to meet the fee of the new category.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A530</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">81</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product, identical or substantially similar in composition and use to a registered product; no data review or only product chemistry data; cite all data citation or selective data citation where applicant owns all required data; or applicant submits specific authorization letter from data owner. Category also includes 100% re-package of registered end-use or manufacturing use product that requires no data submission nor data matrix. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 1,278</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/527">133 STAT. 527</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A531</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">82</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; identical or substantially similar in composition and use to a registered product; registered source of active ingredient: selective data citation only for data on product chemistry and/or acute toxicity and/or public health pest efficacy, where applicant does not own all required data and does not have a specific authorization letter from data owner. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,824</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/528">133 STAT. 528</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A532</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">83</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; identical or substantially similar in composition and use to a registered product; registered active ingredient; unregistered source of active ingredient; cite-all data citation except for product chemistry; product chemistry data submitted. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,107</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A540</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">84</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New end use product; FIFRA §2(mm) uses only; up to 25 public health organisms. (2)(3)(5)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 5,107</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A541</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">85 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New end use product; FIFRA §2(mm) uses only; 26–50 public health organisms. (2)(3)(5)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8,500</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A542</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">86 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New end use product; FIFRA §2(mm) uses only; ≥ 51 public health organisms. (2)(3)(5)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15,000</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/529">133 STAT. 529</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A550</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">87</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New end-use product; uses other than FIFRA §2(mm); non-FQPA product. (2)(3)(5)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13,226</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A560</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">88</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New manufacturing use product; registered active ingredient; selective data citation. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,596</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A565</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">89 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New manufacturing-use product; registered active ingredient; unregistered source of active ingredient; submission of new generic data package; registered uses only; requires science review. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18,234</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A570</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">90</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Label amendment requiring data review; up to 25 public health organisms. (3)(4)(5)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3,831</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A573</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">91 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Label amendment requiring data review; 26–50 public health organisms. (2)(3)(5)(7)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6,350</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/530">133 STAT. 530</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A574</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">92 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Label amendment requiring data review; ≥ 51 public health organisms. (2)(3)(5)(7)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11,000</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">A572</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">93</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New Product or amendment requiring data review for risk assessment by Science Branch (e.g., changes to REI, or PPE, or use rate). (2)(3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">13,226</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 10. — ANTIMICROBIALS DIVISION — EXPERIMENTAL USE PERMITS AND OTHER ACTIONS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e3196"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3196"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3204"><num>(2)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A520</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">94</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Experimental Use Permit application, non-food use. <ref class="footnoteRef" idref="fn-d163463e3204">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 6,383</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/532">133 STAT. 532</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A521</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">95</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Review of public health efficacy study protocol within AD, per AD Internal Guidance for the Efficacy Protocol Review Process; Code will also include review of public health efficacy study protocol and data review for devices making pesticidal claims; applicant-initiated; Tier 1.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4,726</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A522</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">96</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Review of public health efficacy study protocol outside AD by members of AD Efficacy Protocol Review Expert Panel; Code will also include review of public health efficacy study protocol and data review for devices making pesticidal claims; applicant-initiated; Tier 2.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,156</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/533">133 STAT. 533</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A537</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">97 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New Active Ingredient/New Use, Experimental Use Permit application; Direct food use; Establish tolerance or tolerance exemption if required. Credit 45% of fee toward new active ingredient/new use application that follows.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 153,156</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A538</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">98 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New Active Ingredient/New Use, Experimental Use Permit application; Indirect food use; Establish tolerance or tolerance exemption if required Credit 45% of fee toward new active ingredient/new use application that follows.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">95,724</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/534">133 STAT. 534</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A539</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">99 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New Active Ingredient/New Use, Experimental Use Permit application; Nonfood use. Credit 45% of fee toward new active ingredient/new use application that follows.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">92,163</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A529</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">100</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Amendment to Experimental Use Permit; requires data review or risk assessment. <ref class="footnoteRef" idref="fn-d163463e3204">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11,429</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A523</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">101</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Review of protocol other than a public health efficacy study (i.e., Toxicology or Exposure Protocols).</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,156</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A571</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">102</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Science reassessment: Cancer risk, refined ecological risk, and/or endangered species; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">95,724</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A533</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">103 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Exemption from the requirement of an Experimental Use Permit. <ref class="footnoteRef" idref="fn-d163463e3204">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,482</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/535">133 STAT. 535</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A534</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">104 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Rebuttal of agency reviewed protocol, applicant initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4,726</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">A535</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">105 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Conditional Ruling on Pre-application Study Waiver or Data Bridging Argument; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,409</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">A536</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">106 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Conditional Ruling on Pre-application Direct Food, Indirect Food, Nonfood use determination; applicant-initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">2,482</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/536">133 STAT. 536</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 11. — BIOPESTICIDES DIVISION — NEW ACTIVE INGREDIENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e3436"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3436"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e3444"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/538">133 STAT. 538</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3453"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B580</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">107</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New active ingredient; food use; petition to establish a tolerance. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">20</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 51,053</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B590</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">108</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; food use; petition to establish a tolerance exemption. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B600</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">109</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; non-food use. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19,146</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B610</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">110</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; Experimental Use Permit application; petition to establish a temporary tolerance or temporary tolerance exemption. <ref class="footnoteRef" idref="fn-d163463e3453">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B611</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">111</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; Experimental Use Permit application; petition to establish permanent tolerance exemption. <ref class="footnoteRef" idref="fn-d163463e3453">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B612</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">112</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; no change to a permanent tolerance exemption. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">17,550</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/537">133 STAT. 537</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B613</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">113</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; petition to convert a temporary tolerance or a temporary tolerance exemption to a permanent tolerance or tolerance exemption. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">17,550</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B620</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">114</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;"> New active ingredient; Experimental Use Permit application; non-food use including crop destruct. <ref class="footnoteRef" idref="fn-d163463e3453">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">6,383</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 12. — BIOPESTICIDES DIVISION — NEW USES</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e3616"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e3616"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/540">133 STAT. 540</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3625"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e3633"><num>(3)</num> Amendment applications to add the new use(s) to registered product labels are covered by the base fee for the new use(s). All items in the covered application must be submitted together in one package. Each application for an additional new product registration and new inert approval(s) that is submitted in the new use application package is subject to the registration service fee for a new product or a new inert approval. However, if a new use application only proposes to register the new use for a new product and there are no amendments in the application, then review of one new product application is covered by the new use fee. All such associated applications that are submitted together will be subject to the new use decision review time. Any application for a new product or an amendment to the proposed labeling (a) submitted subsequent to submission of the new use application and (b) prior to conclusion of its decision review time and (c) containing the same new uses, will be deemed a separate new-use application, subject to a separate registration service fee and new decision review time for a new use. If the new-use application includes non-food (indoor and/or outdoor), and food (outdoor and/or indoor) uses, the appropriate fee is due for each type of new use and the longest decision review time applies to all of the new uses requested in the application. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screen, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new use application.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/541">133 STAT. 541</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3642"><num>(4)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B630</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">115</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> First food use; petition to establish a tolerance exemption. (2)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B631</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">116</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New food use; petition to amend an established tolerance. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B640</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">117</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">First food use; petition to establish a tolerance. (2)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19,146</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B643</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">118</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Food use; petition to amend an established tolerance exemption. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B642</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">119</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">First food use; indoor; food/food handling. (2)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/539">133 STAT. 539</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B644</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">120</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use, no change to an established tolerance or tolerance exemption. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B650</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">121</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use; non-food. (3)(4)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6,383</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B645</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">122 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New food use; Experimental Use Permit application; petition to amend or add a tolerance exemption. <ref class="footnoteRef" idref="fn-d163463e3642">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B646</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">123 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New use; non-food use including crop destruct; Experimental Use Permit application. <ref class="footnoteRef" idref="fn-d163463e3642">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">6,383</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/542">133 STAT. 542</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,8L,8C,xl77,xl36C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 13. — BIOPESTICIDES DIVISION — NEW PRODUCTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 163pt;"/>
<xhtml:col role="reading" style="min-width: 123pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No.</b></xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 163.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 123.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e3815"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3815"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3823"><num>(2)</num> An application for a new end-use product using a source of active ingredient that (a) is not yet registered but (b) has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e3831"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B652</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">124</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New product; registered source of active ingredient; requires petition to amend established tolerance or tolerance exemption; requires 1) submission of product specific data; or 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 12,764</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/543">133 STAT. 543</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B660</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">125</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; registered source of active ingredient(s); identical or substantially similar in composition and use to a registered product. No data review, or only product chemistry data; cite-all data citation, or selective data citation where applicant owns all required data or authorization from data owner is demonstrated. Category includes 100% re-package of registered end-use or manufacturing-use product that requires no data submission or data matrix. For microbial pesticides, the active ingredient(s) must not be re-isolated. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,278</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/544">133 STAT. 544</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B670</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">126</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; registered source of active ingredient(s); requires: 1) submission of product specific data; or 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of a scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,107</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/545">133 STAT. 545</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B671</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; unregistered source of active ingredient(s); requires a petition to amend an established tolerance or tolerance exemption; requires: 1) submission of product specific data; or 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of a scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">17</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 12,764</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/546">133 STAT. 546</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B672</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">128</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; unregistered source of active ingredient(s); non-food use or food use requires: 1) submission of product specific data; or 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of a scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9,118</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/547">133 STAT. 547</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B673</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">129</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product MUP/EP; unregistered source of active ingredient(s); citation of Technical Grade Active Ingredient (TGAI) data previously reviewed and accepted by the Agency. Requires an Agency determination that the cited data supports the new product. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,107</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B674</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">130</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product MUP; Repack of identical registered end-use product as a manufacturing-use product; same registered uses only. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,278</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B675</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">131</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New Product MUP; registered source of active ingredient; submission of completely new generic data package; registered uses only. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9,118</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/548">133 STAT. 548</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B676</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">132</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; more than one active ingredient where one active ingredient is an unregistered source; product chemistry data must be submitted; requires: 1) submission of product specific data, and 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of a scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9,118</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/549">133 STAT. 549</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B677</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">133</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">New end-use non-food animal product with submission of two or more target animal safety studies; includes data and/or waivers of data for only:</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">• product chemistry and/or• acute toxicity and/or• public health pest efficacy and/or• animal safety studies and/or • child resistant packaging. (2)(3)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;">8,820</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/550">133 STAT. 550</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,8/10,f8,9L,8C,xl82,xl9C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 14. — BIOPESTICIDES DIVISION — AMENDMENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="figure" style="width:36pt ; max-width:36pt;"/>
<xhtml:col role="reading" style="min-width: 173pt;"/>
<xhtml:col role="reading" style="min-width: 123pt;"/>
<xhtml:col role="figure" style="width:52pt ; max-width:52pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:36.0pt ; max-width:36.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 173.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 123.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e4029"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:52.0pt ; max-width:52.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:8pt "><footnote id="fn-d163463e4029"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:8pt "><footnote id="fn-d163463e4037"><num>(2)</num> (a) EPA-initiated amendments shall not be charged registration service fees. (b) Registrant-initiated fast-track amendments are to be completed within the timelines specified in FIFRA Section 3(c)(3)(B) and are not subject to registration service fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials Division are to be completed within the timelines specified in FIFRA Section 3(h) and are not subject to registration service fees. (d) Registrant initiated amendments submitted by notification under PR Notices, such as PR Notice 98–10, continue under PR Notice timelines and are not subject to registration service fees. (e) Submissions with data and requiring data review are subject to registration service fees.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:8pt "><footnote id="fn-d163463e4045"><num>(3)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:8pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B621</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">134</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment; Experimental Use Permit; no change to an established temporary tolerance or tolerance exemption. <ref class="footnoteRef" idref="fn-d163463e4045">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 5,107</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B622</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">135</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment; Experimental Use Permit; petition to amend an established or temporary tolerance or tolerance exemption. <ref class="footnoteRef" idref="fn-d163463e4045">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B641</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">136</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amendment of an established tolerance or tolerance exemption.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B680</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">137</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Amendment; registered sources of active ingredient(s); no new use(s); no changes to an established tolerance or tolerance exemption. Requires data submission. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 5,107</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B681</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">138</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Amendment; unregistered source of active ingredient(s). Requires data submission. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6,079</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B683</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">139</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Label amendment; requires review/update of previous risk assessment(s) without data submission (e.g., labeling changes to REI, PPE, PHI). (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,107</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B684</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">140</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Amending non-food animal product that includes submission of target animal safety data; previously registered. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">8,820</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/551">133 STAT. 551</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B685</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">141 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;"> Amendment; add a new biochemical unregistered source of active ingredient or a new microbial production site. Requires submission of analysis of samples data and source/production site-specific manufacturing process description. <ref class="footnoteRef" idref="fn-d163463e4045">(3)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">5,107</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/552">133 STAT. 552</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 15. — BIOPESTICIDES DIVISION — SCLP</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e4209"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4209"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4217"><num>(2)</num> All requests for new uses (food and/or nonfood) contained in any application for a new active ingredient or a first food use are covered by the base fee for that new active ingredient or first food use application and retain the same decision time review period as the new active ingredient or first food use application. The application must be received by the agency in one package. The base fee for the category covers a maximum of five new products. Each application for an additional new product registration and new inert approval that is submitted in the new active ingredient application package or first food use application package is subject to the registration service fee for a new product or a new inert approval. All such associated applications that are submitted together will be subject to the new active ingredient or first food use decision review time. In the case of a new active ingredient application, until that new active ingredient is approved, any subsequent application for another new product containing the same active ingredient or an amendment to the proposed labeling will be deemed a new active ingredient application, subject to the registration service fee and decision review time for a new active ingredient. In the case of a first food use application, until that first food use is approved, any subsequent application for an additional new food use or uses will be subject to the registration service fee and decision review time for a first food use. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screening, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new active ingredient or first food use application.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e4225"><num>(3)</num> An application for a new end-use product using a source of active ingredient that (a) is not yet registered but (b) has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/556">133 STAT. 556</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4234"><num>(4)</num> (a) EPA-initiated amendments shall not be charged registration service fees. (b) Registrant-initiated fast-track amendments are to be completed within the timelines specified in FIFRA Section 3(c)(3)(B) and are not subject to registration service fees. (c) Registrant-initiated fast-track amendments handled by the Antimicrobials Division are to be completed within the timelines specified in FIFRA Section 3(h) and are not subject to registration service fees. (d) Registrant initiated amendments submitted by notification under PR Notices, such as PR Notice 98–10, continue under PR Notice timelines and are not subject to registration service fees. (e) Submissions with data and requiring data review are subject to registration service fees.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4242"><num>(5)</num> Amendment applications to add the new use(s) to registered product labels are covered by the base fee for the new use(s). All items in the covered application must be submitted together in one package. Each application for an additional new product registration and new inert approval(s) that is submitted in the new use application package is subject to the registration service fee for a new product or a new inert approval. However, if a new use application only proposes to register the new use for a new product and there are no amendments in the application, then review of one new product application is covered by the new use fee. All such associated applications that are submitted together will be subject to the new use decision review time. Any application for a new product or an amendment to the proposed labeling (a) submitted subsequent to submission of the new use application and (b) prior to conclusion of its decision review time and (c) containing the same new uses, will be deemed a separate new-use application, subject to a separate registration service fee and new decision review time for a new use. If the new-use application includes non-food (indoor and/or outdoor), and food (outdoor and/or indoor) uses, the appropriate fee is due for each type of new use and the longest decision review time applies to all of the new uses requested in the application. Any information that (a) was neither requested nor required by the Agency, and (b) is submitted by the applicant at the applicant’s initiative to support the application after completion of the technical deficiency screen, and (c) is not itself a covered registration application, must be assessed 25% of the full registration service fee for the new use application.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4250"><num>(6)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B690</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">142</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New active ingredient; food or non-food use. (2)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 2,554</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B700</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">143</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Experimental Use Permit application; new active ingredient or new use. <ref class="footnoteRef" idref="fn-d163463e4250">(6)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,278</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B701</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">144</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> Extend or amend Experimental Use Permit. <ref class="footnoteRef" idref="fn-d163463e4250">(6)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,278</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/553">133 STAT. 553</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B710</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">145</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; registered source of active ingredient(s); identical or substantially similar in composition and use to a registered product; no change in an established tolerance or tolerance exemption. No data review, or only product chemistry data; cite-all data citation, or selective data citation where applicant owns all required data or authorization from data owner is demonstrated. Category includes 100% re-package of registered end-use or manufacturing-use product that requires no data submission or data matrix. (3)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 1,278</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/554">133 STAT. 554</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B720</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">146</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; registered source of active ingredient(s); requires: 1) submission of product specific data; or 2) citation of previously reviewed and accepted data; or 3) submission or citation of data generated at government expense; or 4) submission or citation of a scientifically-sound rationale based on publicly available literature or other relevant information that addresses the data requirement; or 5) submission of a request for a data requirement to be waived supported by a scientifically-sound rationale explaining why the data requirement does not apply. (3)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,278</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/555">133 STAT. 555</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B721</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">147</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> New product; unregistered source of active ingredient. (3)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,676</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B722</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">148</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New use and/or amendment; petition to establish a tolerance or tolerance exemption. (4)(5)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,477</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B730</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">149</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Label amendment requiring data submission. (4)(6)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">1,278</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/557">133 STAT. 557</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12L'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 16. — BIOPESTICIDES DIVISION — OTHER ACTIONS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e4416"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4416"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B614</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">150</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Pre-application; Conditional Ruling on rationales for addressing a data requirement in lieu of data; applicant-initiated; applies to one rationale at a time.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 2,530</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B615</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">151</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Rebuttal of agency reviewed protocol, applicant initiated.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,530</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B682</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">152</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Protocol review; applicant initiated; excludes time for HSRB review.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">2,432</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<page identifier="/us/stat/133/558">133 STAT. 558</page>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,5C,xl75,xl30C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 17. — BIOPESTICIDES DIVISION — PIP</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:26pt ; max-width:26pt;"/>
<xhtml:col role="reading" style="min-width: 167pt;"/>
<xhtml:col role="reading" style="min-width: 129pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:26.0pt ; max-width:26.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 167.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 129.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e4512"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4512"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4520"><num>(2)</num> New PIP = a PIP with an active ingredient that has not been registered.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4528"><num>(3)</num> Registered PIP = a PIP with an active ingredient that is currently registered.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4536"><num>(4)</num> Transfer registered PIP through conventional breeding for new food/feed use, such as from field corn to sweet corn.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4544"><num>(5)</num> The scientific data involved in this category are complex. EPA often seeks technical advice from the Scientific Advisory Panel on risks that pesticides pose to wildlife, farm workers, pesticide applicators, non-target species, as well as insect resistance, and novel scientific issues surrounding new technologies. The scientists of the SAP neither make nor recommend policy decisions. They provide advice on the science used to make these decisions. Their advice is invaluable to the EPA as it strives to protect humans and the environment from risks posed by pesticides. Due to the time it takes to schedule and prepare for meetings with the SAP, additional time and costs are needed.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4552"><num>(6)</num> Registered PIPs stacked through conventional breeding.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e4561"><num>(7)</num> Deployment of a registered PIP with a different IRM plan (e.g., seed blend).</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/569">133 STAT. 569</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4570"><num>(8)</num> The negotiated acreage cap will depend upon EPA’s determination of the potential environmental exposure, risk(s) to non-target organisms, and the risk of targeted pest developing resistance to the pesticidal substance. The uncertainty of these risks may reduce the allowable acreage, based upon the quantity and type of non-target organism data submitted and the lack of insect resistance management data, which is usually not required for seed-increase registrations. Registrants are encouraged to consult with EPA prior to submission of a registration application in this category.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4578"><num>(9)</num> Application can be submitted prior to or concurrently with an application for commercial registration.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4586"><num>(10)</num> For example, IRM plan modifications that are applicant-initiated.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4594"><num>(11)</num> EPA-initiated amendments shall not be charged fees.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e4602"><num>(12)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B740</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">153</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Experimental Use Permit application; no petition for tolerance/tolerance exemption. Includes:</xhtml:td><xhtml:td leaders="yes" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"><inline/></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1. non-food/feed use(s) for a new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> or registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP (12);</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>2. food/feed use(s) for a new or registered PIP with crop destruct (12);</inline></xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>3. food/feed use(s) for a new or registered PIP in which an established tolerance/tolerance exemption exists for the intended use(s). (4)(12)</inline></xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>6</inline></xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"> 95,724</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/559">133 STAT. 559</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B741</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">154 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Experimental Use Permit application; no petition for tolerance/tolerance exemption. Includes:</xhtml:td><xhtml:td leaders="yes" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"><inline/></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1. non-food/feed use(s) for a new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> or registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP;</xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>2. food/feed use(s) for a new or registered PIP with crop destruct;</inline></xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>3. food/feed use(s) for a new or registered PIP in which an established tolerance/tolerance exemption exists for the intended use(s);</inline></xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>SAP Review. (12)</inline></xhtml:td><xhtml:td leaders="yes" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><inline>12</inline></xhtml:td><xhtml:td leaders="no" style=" text-align:left; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;">159,538</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B750</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">155</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Experimental Use Permit application; with a petition to establish a temporary or permanent tolerance/tolerance exemption for the active ingredient. Includes new food/feed use for a registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP. (4)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127,630</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/560">133 STAT. 560</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B770</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">156</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Experimental Use Permit application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; with petition to establish a temporary tolerance/tolerance exemption for the active ingredient; credit 75% of B771 fee toward registration application for a new active ingredient that follows; SAP review. (5)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 191,444</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B771</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">157</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Experimental Use Permit application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; with petition to establish a temporary tolerance/tolerance exemption for the active ingredient; credit 75% of B771 fee toward registration application for a new active ingredient that follows. (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">10</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127,630</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B772</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">158</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Application to amend or extend an Experimental Use Permit; no petition since the established tolerance/tolerance exemption for the active ingredient is unaffected. (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/561">133 STAT. 561</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B773</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">159</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Application to amend or extend an Experimental Use Permit; with petition to extend a temporary tolerance/tolerance exemption for the active ingredient. (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B780</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">160</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; non-food/feed. (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">159,537</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B790</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">161</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; non-food/feed; SAP review. (5)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">223,351</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B800</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">162</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; with petition to establish permanent tolerance/tolerance exemption for the active ingredient based on an existing temporary tolerance/tolerance exemption. (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">172,300</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/562">133 STAT. 562</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B810</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">163</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; with petition to establish permanent tolerance/tolerance exemption for the active ingredient based on an existing temporary tolerance/tolerance exemption. SAP review. (5)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">19</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">236,114</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B820</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">164</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; with petition to establish or amend a permanent tolerance/tolerance exemption of an active ingredient. (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">204,208</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B840</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">165</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP; with petition to establish or amend a permanent tolerance/tolerance exemption of an active ingredient. SAP review. (5)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">268,022</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/563">133 STAT. 563</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B851</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">166</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new event of a previously registered PIP active ingredient(s); no petition since permanent tolerance/tolerance exemption is already established for the active ingredient(s). (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127,630</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B870</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">167</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP; new product; new use; no petition since a permanent tolerance/tolerance exemption is already established for the active ingredient(s). <ref class="footnoteRef" idref="fn-d163463e4536">(4)</ref> (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">38,290</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B880</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">168</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP; new product or new terms of registration; additional data submitted; no petition since a permanent tolerance/tolerance exemption is already established for the active ingredient(s). <ref class="footnoteRef" idref="fn-d163463e4552">(6)</ref> <ref class="footnoteRef" idref="fn-d163463e4561">(7)</ref> (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/564">133 STAT. 564</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B881</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">169</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP; new product or new terms of registration; additional data submitted; no petition since a permanent tolerance/tolerance exemption is already established for the active ingredient(s). SAP review. (5)(6)(7)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">95,724</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B882</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">170 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP, seed increase with negotiated acreage cap and time-limited registration; with petition to establish a permanent tolerance/tolerance exemption for the active ingredient based on an existing temporary tolerance/tolerance exemption; SAP Review. (8)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">191,444</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/565">133 STAT. 565</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B883</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">171</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP, seed increase with negotiated acreage cap and time-limited registration; with petition to establish a permanent tolerance/tolerance exemption for the active ingredient based on an existing temporary tolerance/tolerance exemption. <ref class="footnoteRef" idref="fn-d163463e4570">(8)</ref> (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127,630</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B884</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">172</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP, seed increase with negotiated acreage cap and time-limited registration; with petition to establish a permanent tolerance/tolerance exemption for the active ingredient. (8)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">159,537</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B885</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">173</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; registered <ref class="footnoteRef" idref="fn-d163463e4528">(3)</ref> PIP, seed increase; breeding stack of previously approved PIPs, same crop; no petition since a permanent tolerance/tolerance exemption is already established for the active ingredient(s). (9)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,910</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/566">133 STAT. 566</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B886</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">174 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Registration application; new <ref class="footnoteRef" idref="fn-d163463e4520">(2)</ref> PIP, seed increase with negotiated acreage cap and time-limited registration; with petition to establish a permanent tolerance/tolerance exemption for the active ingredient. SAP Review. <ref class="footnoteRef" idref="fn-d163463e4570">(8)</ref> (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">223,351</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B890</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">175</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Application to amend a seed increase registration; converts registration to commercial registration; no petition since permanent tolerance/tolerance exemption is already established for the active ingredient(s). (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63,816</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B891</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">176</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Application to amend a seed increase registration; converts registration to a commercial registration; no petition since a permanent tolerance/tolerance exemption already established for the active ingredient(s); SAP review. (5)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127,630</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/567">133 STAT. 567</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B900</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">177</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Application to amend a registration, including actions such as extending an expiration date, modifying an IRM plan, or adding an insect to be controlled. (10)(11)(12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B901</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">178</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Application to amend a registration, including actions such as extending an expiration date, modifying an IRM plan, or adding an insect to be controlled. SAP review. (10) (11) (12)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">76,578</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B902</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">179</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">PIP Protocol review.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6,383</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B903</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">180</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Inert ingredient tolerance exemption; e.g., a marker such as NPT II; reviewed in BPPD.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63,816</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B904</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">181</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Import tolerance or tolerance exemption; processed commodities/food only (inert or active ingredient).</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">127,630</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B905</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">182 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">SAP Review.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63,816</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/568">133 STAT. 568</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B906</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">183 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Petition to establish a temporary tolerance/tolerance exemption for one or more active ingredients.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">31,907</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">B907</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">184 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Petition to establish a temporary tolerance/tolerance exemption for one or more active ingredients based on an existing temporary tolerance/tolerance exemption.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12,764</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">B908</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">185 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Petition to establish a temporary tolerance/tolerance exemption for one or more active ingredients or inert ingredients.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">44,671</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,7C,xl72,xl44C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 18. — INERT INGREDIENTS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:35pt ; max-width:35pt;"/>
<xhtml:col role="reading" style="min-width: 159pt;"/>
<xhtml:col role="reading" style="min-width: 128pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:35.0pt ; max-width:35.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 159.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 128.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e5178"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5178"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5186"><num>(2)</num> If another covered application is submitted that depends upon an application to approve an inert ingredient, each application will be subject to its respective registration service fee. The decision review time line for both submissions will be the longest of the associated applications. If the application covers multiple ingredients grouped by EPA into one chemical class, a single registration service fee will be assessed for approval of those ingredients.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5194"><num>(3)</num> If EPA data rules are amended to newly require clearance under section 408 of the FFDCA for an ingredient of an antimicrobial product where such ingredient was not previously subject to such a clearance, then review of the data for such clearance of such product is not subject to a registration service fee for the tolerance action for two years from the effective date of the rule.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5202"><num>(4)</num> Any other covered application that is associated with and dependent on the HSRB review will be subject to its separate registration service fee. The decision review times for the associated actions run concurrently, but will end at the date of the latest review time.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5210"><num>(5)</num> Any other covered application that is associated with and dependent on the SAP review will be subject to its separate registration service fee. The decision review time for the associated action will be extended by the decision review time for the SAP review.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5218"><num>(6)</num> An application for a new end-use product using a source of active ingredient that (a) is not yet registered but (b) has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e5227"><num>(7)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/573">133 STAT. 573</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5236"><num>(8)</num> If a new safener is submitted in the same package as a new active ingredient, and that new active ingredient is determined to be reduced risk, then the safener would get the same reduced timeframe as the new active ingredient.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I001</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">186</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new food use inert ingredient. (2)(3)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 27,000</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I002</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">187</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend currently approved inert ingredient tolerance or exemption from tolerance; new data. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">11</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7,500</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I003</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">188</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend currently approved inert ingredient tolerance or exemption from tolerance; no new data. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3,308</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/570">133 STAT. 570</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I004</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">189</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new non-food use inert ingredient. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 11,025</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I005</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">190</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend currently approved non-food use inert ingredient with new use pattern; new data. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,513</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I006</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">191</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Amend currently approved non-food use inert ingredient with new use pattern; no new data. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3,308</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I007</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">192</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of substantially similar non-food use inert ingredients when original inert is compositionally similar with similar use pattern. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,654</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I008</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">193</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new or amended polymer inert ingredient, food use. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3,749</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I009</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">194</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new or amended polymer inert ingredient, non-food use. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">3,087</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/571">133 STAT. 571</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I010</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">195</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Petition to amend a single tolerance exemption descriptor, or single non-food use descriptor, to add ≤ 10 CASRNs; no new data. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">6</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,654</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I011</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">196 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new food use safener with tolerance or exemption from tolerance. (2)(8)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">597,683</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I012</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">197 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new non-food use safener. (2)(8)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">21</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">415,241</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I013</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">198 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of additional food use for previously approved safener with tolerance or exemption from tolerance. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">62,975</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I014</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">199 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of additional non-food use for previously approved safener. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">25,168</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">I015</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">200 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Approval of new generic data for previously approved food use safener. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">24</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">269,728</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/572">133 STAT. 572</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">I016</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">201 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Approval of amendment(s) to tolerance and label for previously approved safener. <ref class="footnoteRef" idref="fn-d163463e5186">(2)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">13</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">55,776</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04?>
<?GPOvSpace 00?>
<xhtml:table xmlns:xhtml="http://www.w3.org/1999/xhtml" class="fullWidth" style="border-collapse:collapse;  -uslm-lc: 'c5,L4(4,4,4,4,4,0),p9,9/10,9L,8C,xl70,xl49C,12C'; "><xhtml:caption role="title" style="font-size:10pt; border-bottom:1px solid black; -uslm-lc:I658095 caption-side:top;">“TABLE 19. — EXTERNAL REVIEW AND MISCELLANEOUS ACTIONS</xhtml:caption>
<xhtml:colgroup><xhtml:col role="figure" style="width:44pt ; max-width:44pt;"/>
<xhtml:col role="figure" style="width:40pt ; max-width:40pt;"/>
<xhtml:col role="reading" style="min-width: 155pt;"/>
<xhtml:col role="reading" style="min-width: 127pt;"/>
<xhtml:col role="figure" style="width:58pt ; max-width:58pt;"/>
</xhtml:colgroup><xhtml:thead><xhtml:tr class="header" style="font-size:9pt; border-top:1px solid black;  border-bottom:1px solid black; -uslm-lc:h1">
<xhtml:th style="width:44.0pt ; max-width:44.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>EPA</b><br/><b>No</b>.</xhtml:th><xhtml:th style="width:40.0pt ; max-width:40.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>New</b><br/><b> CR</b><br/><b>No.</b></xhtml:th><xhtml:th style="min-width: 155.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Action</b></xhtml:th><xhtml:th style="min-width: 127.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b>Decision</b><br/><b>Review Time</b><br/><b> (Months)</b><ref class="footnoteRef" idref="fn-d163463e5521"><sub>(1)</sub></ref></xhtml:th><xhtml:th style="width:58.0pt ; max-width:58.0pt; text-align:center; vertical-align:middle; border-left:1px solid black; border-right:1px solid black;"><b> Registration</b><br/><b> Service Fee</b><br/><b>($)</b></xhtml:th></xhtml:tr>
</xhtml:thead><xhtml:tfoot style=" border-top:1px solid black;"><xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5521"><num>(1)</num> A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5529"><num>(2)</num> If another covered application is submitted that depends upon an application to approve an inert ingredient, each application will be subject to its respective registration service fee. The decision review time line for both submissions will be the longest of the associated applications. If the application covers multiple ingredients grouped by EPA into one chemical class, a single registration service fee will be assessed for approval of those ingredients.</footnote></xhtml:td>
</xhtml:tr>
<tr xmlns="http://www.w3.org/1999/xhtml">
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote xmlns="http://schemas.gpo.gov/xml/uslm" id="fn-d163463e5537"><num>(3)</num> If EPA data rules are amended to newly require clearance under section 408 of the FFDCA for an ingredient of an antimicrobial product where such ingredient was not previously subject to such a clearance, then review of the data for such clearance of such product is not subject to a registration service fee for the tolerance action for two years from the effective date of the rule.</footnote></xhtml:td>
</tr><page identifier="/us/stat/133/578">133 STAT. 578</page>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5546"><num>(4)</num> Any other covered application that is associated with and dependent on the HSRB review will be subject to its separate registration service fee. The decision review times for the associated actions run concurrently, but will end at the date of the latest review time.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5554"><num>(5)</num> Any other covered application that is associated with and dependent on the SAP review will be subject to its separate registration service fee. The decision review time for the associated action will be extended by the decision review time for the SAP review.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5562"><num>(6)</num> An application for a new end-use product using a source of active ingredient that (a) is not yet registered but (b) has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5571"><num>(7)</num> Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5579"><num>(8)</num> Due to low fee and short time frame this category is not eligible for small business waivers. Gold seal applies to one registered product.</footnote></xhtml:td>
</xhtml:tr>
<xhtml:tr>
<xhtml:td colspan="5" style="text-align:justify; text-indent:1em; font-size:9pt "><footnote id="fn-d163463e5587"><num>(9)</num> This category includes amendments the sole purpose of which is to add DfE (or equivalent terms that do not use “safe” or derivatives of “safe”) logos to a label. DfE is a voluntary program. A label bearing a DfE logo is not considered an Agency endorsement because the ingredients in the qualifying product must meet objective, scientific criteria established and widely publicized by EPA.”.</footnote></xhtml:td>
</xhtml:tr>
</xhtml:tfoot><xhtml:tbody style="line-height:10pt; font-size:9pt;"><xhtml:tr style="border-top:1px solid black; border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M001</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">202</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Study protocol requiring Human Studies Review Board review as defined in <ref href="/us/cfr/t40/pt26">40 CFR Part 26</ref> in support of an active ingredient. <ref class="footnoteRef" idref="fn-d163463e5546">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;"> 7,938</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M002</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">203</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Completed study requiring Human Studies Review Board review as defined in <ref href="/us/cfr/t40/pt26">40 CFR Part 26</ref> in support of an active ingredient. <ref class="footnoteRef" idref="fn-d163463e5546">(4)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">7,938</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/574">133 STAT. 574</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M003</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">204</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">External technical peer review of new active ingredient, product, or amendment (e.g., consultation with FIFRA Scientific Advisory Panel) for an action with a decision timeframe of less than 12 months. Applicant initiated request based on a requirement of the Administrator, as defined by FIFRA § 25(d), in support of a novel active ingredient, or unique use pattern or application technology. Excludes PIP active ingredients. <ref class="footnoteRef" idref="fn-d163463e5554">(5)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63,945</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/575">133 STAT. 575</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M004</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">205</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">External technical peer review of new active ingredient, product, or amendment (e.g., consultation with FIFRA Scientific Advisory Panel) for an action with a decision timeframe of greater than 12 months. Applicant initiated request based on a requirement of the Administrator, as defined by FIFRA § 25(d), in support of a novel active ingredient, or unique use pattern or application technology. Excludes PIP active ingredients. <ref class="footnoteRef" idref="fn-d163463e5554">(5)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">18</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">63,945</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/576">133 STAT. 576</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M005</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">206</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">New Product: Combination, Contains a combination of active ingredients from a registered and/or unregistered source; conventional, antimicrobial and/or biopesticide. Requires coordination with other regulatory divisions to conduct review of data, label and/or verify the validity of existing data as cited. Only existing uses for each active ingredient in the combination product. (6)(7)</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">9</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">22,050</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M006</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">207</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Request for up to 5 letters of certification (Gold Seal) for one actively registered product (excludes distributor products). <ref class="footnoteRef" idref="fn-d163463e5579">(8)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">277</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M007</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">208</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Request to extend Exclusive Use of data as provided by FIFRA Section 3(c)(1)(F)(ii).</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">12</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">5,513</xhtml:td></xhtml:tr>
<page identifier="/us/stat/133/577">133 STAT. 577</page>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M008</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">209</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Request to grant Exclusive Use of data as provided by FIFRA Section 3(c)(1)(F)(vi) for a minor use, when a FIFRA Section 2(ll)(2) determination is required.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">15</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">1,654</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M009</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">210 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Non-FIFRA Regulated Determination: Applicant initiated, per product.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,363</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">M010</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">211 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">Conditional ruling on pre-application, product substantial similarity.</xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black;">2,363</xhtml:td></xhtml:tr>
<xhtml:tr style="border-right:1px solid black; border-left:1px solid black; -uslm-lc:I01"><xhtml:td leaders="no" stubHierarchy="1" style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">M011</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">212 (new)</xhtml:td><xhtml:td style=" text-align:left; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">Label amendment to add the DfE logo; requires data review; no other label changes. <ref class="footnoteRef" idref="fn-d163463e5587">(9)</ref></xhtml:td><xhtml:td style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">4</xhtml:td><xhtml:td leaders="no" style=" text-align:center; vertical-align:top; border-left:1px solid black; border-right:1px solid black;">3,648</xhtml:td></xhtml:tr>
</xhtml:tbody></xhtml:table><?GPOvSpace 04 ''.?></content></section>
<section id="d163679e6736" identifier="/us/pl/116/8/s7" style="-uslm-lc:I658141"><num class="fontsize12" value="7">SEC. 7. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbcf34df1-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Time periods.</p><p class="leftAlign firstIndent0 fontsize8" id="xbcf34df2-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Regulations.</p></sidenote><heading>AGRICULTURAL WORKER PROTECTION STANDARD; CERTIFICATION OF PESTICIDE APPLICATORS.</heading><subsection class="firstIndent0 fontsize10" id="ybcf3c323-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c324-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180"><ref href="/us/usc/t7/s136w">7 USC 136w note</ref>.</p></sidenote>.—</heading><chapeau>Except as provided in subsection (b), during the period beginning on the date of enactment of this Act and ending not earlier than October 1, 2021, the Administrator of the Environmental Protection Agency (referred to in this section as the “Administrator”)—</chapeau><paragraph class="fontsize10" id="ybcf3c325-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>shall carry out—</chapeau><subparagraph class="fontsize10" id="ybcf3c326-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/a/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>the final rule of the Administrator entitled “Pesticides; Agricultural Worker Protection Standard Revisions” (<ref href="/us/fr/80/67496">80 Fed. Reg. 67496</ref> (November 2, 2015)); and</content></subparagraph>
<subparagraph class="fontsize10" id="ybcf3c327-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/a/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>the final rule of the Administrator entitled “Pesticides; Certification of Pesticide Applicators” (<ref href="/us/fr/82/952">82 Fed. Reg. 952</ref> (January 4, 2017)); and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="ybcf3c328-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>shall not revise or develop revisions to the rules described in subparagraphs (A) and (B) of paragraph (1).</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="ybcf3c329-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Exceptions</inline><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c32a-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Deadline.</p><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c32b-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Notice.</p><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c32c-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Public comments.</p><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c32d-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180"><ref href="/us/usc/t7/s136w">7 USC 136w note</ref>.</p></sidenote>.—</heading><content>Prior to October 1, 2021, the Administrator may propose, and after a notice and public comment period of not less than 90 days, promulgate revisions to the final rule described in subsection (a)(1)(A) addressing application exclusion zones under <ref href="/us/cfr/t40/pt170">part 170 of title 40, Code of Federal Regulations</ref>, <page identifier="/us/stat/133/579">133 STAT. 579</page>
consistent with the Federal Insecticide, Fungicide, and Rodenticide Act (<ref href="/us/usc/t7/s136/etseq">7 U.S.C. 136 et seq.</ref>).</content></subsection>
<subsection class="firstIndent0 fontsize10" id="ybcf3c32e-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/c" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><inline class="smallCaps">GAO Report</inline>.—</heading><chapeau>The Comptroller General of the United States shall—</chapeau><paragraph class="fontsize10" id="ybcf3c32f-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/c/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c330-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Study.</p></sidenote><content>conduct a study on the use of the designated representative, including the effect of that use on the availability of pesticide application and hazard information and worker health and safety; and</content></paragraph>
<paragraph class="fontsize10" id="ybcf3c331-e81e-11f0-bc57-ad3ac4b1618c" identifier="/us/pl/116/8/s7/c/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c332-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Public information.</p><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c333-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">Recommenda-</p><p class="leftAlign firstIndent0 fontsize8" id="xbcf3c334-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658180">tions.</p></sidenote><content>not later than October 1, 2021, make publically available a report describing the study under paragraph (1), including any recommendations to prevent the misuse of pesticide application and hazard information, if that misuse is identified.</content></paragraph>
</subsection>
</section>
<action>
<actionDescription style="-uslm-lc:I658030">Approved</actionDescription> <date date="2019-03-08">March 8, 2019</date>.</action>
</main>
<legislativeHistory>
<heading style="-uslm-lc:I658031"><inline class="underline">LEGISLATIVE HISTORY</inline>—<ref href="/us/bill/116/s/483">S. 483</ref>:</heading>
<note>
<heading style="-uslm-lc:I658032">CONGRESSIONAL RECORD, Vol. 165 (2019):</heading>
<p class="indentUp4 firstIndent-1" id="xbcf3c335-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658035">Feb. 14, considered and passed Senate.</p><p class="indentUp4 firstIndent-1" id="xbcf3c336-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658035">Feb. 25, considered and passed House, amended.</p><p class="indentUp4 firstIndent-1" id="xbcf3c337-e81e-11f0-bc57-ad3ac4b1618c" style="-uslm-lc:I658035">Feb. 28, Senate concurred in House amendment.</p></note>
</legislativeHistory>
<endMarker>○</endMarker>
</pLaw>